# Combination Chemotherapy in Treating Patients With Sarcoma

> **NCT00662233** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 28 (actual)

## Conditions studied

- Ovarian Cancer
- Sarcoma

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** vincristine sulfate
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** brachytherapy
- **RADIATION:** intraoperative radiation therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00662233
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-10
- **Primary completion:** 2013-10-21
- **Final completion:** 2013-10-21
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662233, "Combination Chemotherapy in Treating Patients With Sarcoma". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00662233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*